Corneal collagen cross-linking in the stabilization of PRK, LASIK, thermal keratoplasty, and orthokeratology

Michelle K. Nguyen, Roy S. Chuck

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: To describe the use of corneal collagen cross-linking (CXL) and its efficacy in the stabilization of keratorefractive procedures, including PRK, laser in-situ keratomileusis (LASIK), thermal keratoplasty, and orthokeratology. RECENT FINDINGS: Since its introduction, CXL has quickly gained interest in the treatment of ectactic disorders due to its ability to increase the biomechanical stability of the cornea. In its earliest use, it has shown to be effective in the treatment of both keratoconus and post-LASIK ectasia. More recent studies of CXL in combination with keratorefractive procedures have shown varying degrees of success. SUMMARY: CXL with PRK has shown to be effective in slowing or halting the progression of keratoconus, pellucid marginal degeneration, and post-LASIK ectasia, in addition to potentially decreasing or delaying the need for penetrating keratoplasty. Several small case series have also demonstrated improved stability and efficacy of PRK and LASIK when combined with CXL, as well as a potentially decreased risk of postprocedure ectasia. In conjunction with thermokeratoplasty and orthokeratology, CXL has shown improved but only temporary results in the treatment of keratoconus. Future studies are needed to determine the efficacy and long-term stability of CXL in combination with keratorefractive procedures, as well as to address possible complications.

Original languageEnglish (US)
Pages (from-to)291-295
Number of pages5
JournalCurrent Opinion in Ophthalmology
Volume24
Issue number4
DOIs
StatePublished - Jul 2013

Fingerprint

Laser In Situ Keratomileusis
Corneal Transplantation
Pathologic Dilatations
Keratoconus
Collagen
Hot Temperature
Penetrating Keratoplasty
Cornea
Therapeutics

Keywords

  • cross-linking
  • ectasia
  • laser in-situ keratomileusis
  • orthokeratology
  • photorefractive keratectomy
  • thermal keratoplasty

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Corneal collagen cross-linking in the stabilization of PRK, LASIK, thermal keratoplasty, and orthokeratology. / Nguyen, Michelle K.; Chuck, Roy S.

In: Current Opinion in Ophthalmology, Vol. 24, No. 4, 07.2013, p. 291-295.

Research output: Contribution to journalArticle

@article{acb8d183f3ff4f7d907b33052bc08676,
title = "Corneal collagen cross-linking in the stabilization of PRK, LASIK, thermal keratoplasty, and orthokeratology",
abstract = "PURPOSE OF REVIEW: To describe the use of corneal collagen cross-linking (CXL) and its efficacy in the stabilization of keratorefractive procedures, including PRK, laser in-situ keratomileusis (LASIK), thermal keratoplasty, and orthokeratology. RECENT FINDINGS: Since its introduction, CXL has quickly gained interest in the treatment of ectactic disorders due to its ability to increase the biomechanical stability of the cornea. In its earliest use, it has shown to be effective in the treatment of both keratoconus and post-LASIK ectasia. More recent studies of CXL in combination with keratorefractive procedures have shown varying degrees of success. SUMMARY: CXL with PRK has shown to be effective in slowing or halting the progression of keratoconus, pellucid marginal degeneration, and post-LASIK ectasia, in addition to potentially decreasing or delaying the need for penetrating keratoplasty. Several small case series have also demonstrated improved stability and efficacy of PRK and LASIK when combined with CXL, as well as a potentially decreased risk of postprocedure ectasia. In conjunction with thermokeratoplasty and orthokeratology, CXL has shown improved but only temporary results in the treatment of keratoconus. Future studies are needed to determine the efficacy and long-term stability of CXL in combination with keratorefractive procedures, as well as to address possible complications.",
keywords = "cross-linking, ectasia, laser in-situ keratomileusis, orthokeratology, photorefractive keratectomy, thermal keratoplasty",
author = "Nguyen, {Michelle K.} and Chuck, {Roy S.}",
year = "2013",
month = "7",
doi = "10.1097/ICU.0b013e3283622d51",
language = "English (US)",
volume = "24",
pages = "291--295",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Corneal collagen cross-linking in the stabilization of PRK, LASIK, thermal keratoplasty, and orthokeratology

AU - Nguyen, Michelle K.

AU - Chuck, Roy S.

PY - 2013/7

Y1 - 2013/7

N2 - PURPOSE OF REVIEW: To describe the use of corneal collagen cross-linking (CXL) and its efficacy in the stabilization of keratorefractive procedures, including PRK, laser in-situ keratomileusis (LASIK), thermal keratoplasty, and orthokeratology. RECENT FINDINGS: Since its introduction, CXL has quickly gained interest in the treatment of ectactic disorders due to its ability to increase the biomechanical stability of the cornea. In its earliest use, it has shown to be effective in the treatment of both keratoconus and post-LASIK ectasia. More recent studies of CXL in combination with keratorefractive procedures have shown varying degrees of success. SUMMARY: CXL with PRK has shown to be effective in slowing or halting the progression of keratoconus, pellucid marginal degeneration, and post-LASIK ectasia, in addition to potentially decreasing or delaying the need for penetrating keratoplasty. Several small case series have also demonstrated improved stability and efficacy of PRK and LASIK when combined with CXL, as well as a potentially decreased risk of postprocedure ectasia. In conjunction with thermokeratoplasty and orthokeratology, CXL has shown improved but only temporary results in the treatment of keratoconus. Future studies are needed to determine the efficacy and long-term stability of CXL in combination with keratorefractive procedures, as well as to address possible complications.

AB - PURPOSE OF REVIEW: To describe the use of corneal collagen cross-linking (CXL) and its efficacy in the stabilization of keratorefractive procedures, including PRK, laser in-situ keratomileusis (LASIK), thermal keratoplasty, and orthokeratology. RECENT FINDINGS: Since its introduction, CXL has quickly gained interest in the treatment of ectactic disorders due to its ability to increase the biomechanical stability of the cornea. In its earliest use, it has shown to be effective in the treatment of both keratoconus and post-LASIK ectasia. More recent studies of CXL in combination with keratorefractive procedures have shown varying degrees of success. SUMMARY: CXL with PRK has shown to be effective in slowing or halting the progression of keratoconus, pellucid marginal degeneration, and post-LASIK ectasia, in addition to potentially decreasing or delaying the need for penetrating keratoplasty. Several small case series have also demonstrated improved stability and efficacy of PRK and LASIK when combined with CXL, as well as a potentially decreased risk of postprocedure ectasia. In conjunction with thermokeratoplasty and orthokeratology, CXL has shown improved but only temporary results in the treatment of keratoconus. Future studies are needed to determine the efficacy and long-term stability of CXL in combination with keratorefractive procedures, as well as to address possible complications.

KW - cross-linking

KW - ectasia

KW - laser in-situ keratomileusis

KW - orthokeratology

KW - photorefractive keratectomy

KW - thermal keratoplasty

UR - http://www.scopus.com/inward/record.url?scp=84880135142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880135142&partnerID=8YFLogxK

U2 - 10.1097/ICU.0b013e3283622d51

DO - 10.1097/ICU.0b013e3283622d51

M3 - Article

C2 - 23736897

AN - SCOPUS:84880135142

VL - 24

SP - 291

EP - 295

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 4

ER -